Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.5.1.18 (
glutathione S-transferase
)
22,582
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
With the aim of identifying potential cellular proteins that mediate the transcriptional regulation of YY1, a HeLa cDNA library was screened using the yeast two-hybrid system. A previously unknown protein interacting with YY1 was identified and named
YY1AP
. By using the 5'-rapid amplification of cDNA ends technique, the full-length cDNA of
YY1AP
was cloned and sequenced. The cDNA was 2253 bp in length and encoded an open reading frame of 750 amino acids. The chromosomal gene was made up of 10 exons separated by nine introns and is localized on chromosome 1 (1q21.3). Northern blot analysis revealed that
YY1AP
is ubiquitously expressed in various human tissues and cancer cell lines. Co-immunoprecipitation and immunostaining of cells further indicated that
YY1AP
co-localizes with YY1 in the nucleus. Furthermore,
YY1AP
was shown to be capable of enhancing the transcriptional activation of an YY1 responsive promoter. Subsequent analysis by
glutathione S-transferase
pull-down assay showed that
YY1AP
contained two YY1 binding regions. The transactivation region of
YY1AP
would seem to be localized within the section of amino acids 260-345. It is proposed that
YY1AP
is a novel co-activator of YY1.
...
PMID:YY1AP, a novel co-activator of YY1. 1474 66